Today, LTS Nutraceuticals, makers of a unique line of high-quality personal care, vitamin, supplement and neutraceutical offerings, reported completion of the Biocalth International, Inc., Giantceuticals, Inc. and HerbSource Enterprises, Inc. acquisitions, resulting in a business entity that has considerable striking distance in both European and Asian markets.
CEO of LTSN, Jerry Rayman, pointed out that this strategic acquisition includes additional manufacturing infrastructure. With Biocalth® products already established in the bone health segment, the expanded production capability will allow LTSN to greater cement its position in domestic markets while obtaining penetration into particularly ideal Asian markets. The patented Calcium L-Threonate supplement product Biocalth, appeals not only to the thriving Asian market but to growing numbers of retiring baby boomers here in the US, who are keen on maintaining quality of life.
Indeed, Biocalth has built up quite a reputation over the last decade plus of activity developing and marketing proprietary nutritionals (focus on calcium supplements), while their botanical extract/food additive/vitamin formulation division, HerbSource Enterprises, Inc., shored up coverage in the broader supplement category. Ensuring regulatory standards are met for all raw ingredients, Biocalth manufactures at its GMP-compliant 25k square foot state-of-the-art facility, which meets all required standards set for US/EU governments/pharmaceutical agencies.
President and CEO of Biocalth, Jackson Wen, affirmed the decision, adding that the combined business entity will be more able to become a “global powerhouse within the nutraceutical market.”
The logic here is simple: we have Biocalth, with a strong Asian manufacturing and distribution footing, as well as solid product recognition, combined with the primary US unit that has a similar domestic footing with access to EU markets. LTSN leverages its proficiencies in direct selling via Inline Marketing, where direct access to consumers via national retail, drug, grocery chain and club store locations allows the Company to tightly close the production/consumption loop. The acquisition has created a market-spanning supplement business with unique, attractive offerings for all targets.
There is abundant potential in the US for Biocalth, as retiring Americans look for a healthy calcium supplement to improve bone density and encourage cartilage/collagen formation in connective joints and tissues. This market is really quite large, with the domestic bone/joint health market representing the largest segment globally of what is projected to be a $9B market by 2017.
LTSN is a forward-thinking nutritionals company founded by Ted Farnsworth with a vision to create the powerful vitamins and nutrient-rich products he desperately sought and could not find himself after undergoing a gastric bypass surgery nearly a decade ago. That same vision today drives the Company forward as it embarks upon this striking out into global markets via the Biocalth acquisition.
For more information about the acquisition, or to stay up on the latest news at LTS Nutraceuticals, Inc., please visit the Company website at www.LTSNinc.com
Let us hear your thoughts below:
